Rapid Sequence Induction With a Standard Intubation Dose of Rocuronium After Magnesium Pretreatment Compared With...

Area of Science:

• Anesthesiology
• Pharmacology
• Critical Care Medicine

Background:

• Succinylcholine is the standard muscle relaxant for rapid sequence induction (RSI) but carries adverse effects.
• High-dose rocuronium is an alternative, but with prolonged recovery.
• Magnesium sulfate (MgSO4) can shorten rocuronium's onset time.

Purpose of the Study:

• To compare the efficacy of intravenous (IV) MgSO4 pretreatment followed by a standard dose of rocuronium versus succinylcholine for RSI.
• To evaluate intubating conditions and adverse events associated with each method.

Main Methods:

• A randomized trial involving 280 adult patients undergoing RSI.
• Group 1 received IV MgSO4 followed by rocuronium.
• Group 2 received IV saline followed by succinylcholine.
• Intubating conditions were assessed 60 seconds post-administration; adverse events were monitored for 24 hours.

Main Results:

• No significant difference in excellent intubating conditions between MgSO4-rocuronium (46%) and saline-succinylcholine (45%) groups.
• Women showed significantly better intubating conditions than men.
• The MgSO4-rocuronium group had significantly fewer adverse events (11%) compared to the succinylcholine group (28%).

Conclusions:

• IV MgSO4 pretreatment with rocuronium does not offer superior intubation conditions compared to succinylcholine for RSI.
• The MgSO4-rocuronium combination demonstrates a significantly lower incidence of adverse effects.
• This combination may represent a safer alternative for RSI despite similar intubating condition rates.